COVID-19 and the Path to Immunity – JAMA Commentary on Twitter Declines in SARSCoV2 IgG neutralizing Abs raise concerns of susceptibility to reinfection. But acute Ab levels always decline post-infection, and Ab recall responses come from a pool of long-lived memory B cells https://t.co/geGOQkhdw2 — JAMA (@JAMA_current) September 12, 2020
The post Viewpoint: COVID-19 and the path to immunity appeared first on Links Medicus.
Positive end-expiratory pressure-induced recruited lung volume measured by volume-pressure curves in acute respiratory distress syndrome: a physiologic systematic review and meta-analysis – Intensive Care Medicine Commentary on Twitter PEEP-induced recruited lung volume measuredby VP curves in #ARDS, systematic review: after PEEP increment most pts are recruiters (Vrec > 150ml, 74%). #ICU mortality no significantly […]
The post Meta-analysis: PEEP-induced recruited lung volume measured by volume-pressure curves in ARDS appeared first on Links Medicus.
A COVID-19 Vaccine May Be Only 50% Effective. Is That Good Enough? – NPR
The post A COVID-19 vaccine may be only 50% effective. Is that good enough? appeared first on Links Medicus.
Drug treatments for covid-19: living systematic review and network meta-analysis – The BMJ Commentary on Twitter Our first update of our living NMA on treatments for covid-19 is published today: https://t.co/xRiSBkuRyG#COVID19 — ReedSiemieniuk. (@RSiemieniuk) September 11, 2020
The post Updated meta-analysis: Drug treatments for Covid-19 appeared first on Links Medicus.
|
|||||||||||||||||||
Bacterial and fungal superinfections in critically ill patients with COVID-19 – Intensive Care Medicine Commentary on Twitter Bacterial/fungal superinfections in critically ill #COVID19 pts: true prevalence still elusive. Underestimation of late superinfection risk may occur in #ICU; confounding factors also hamper identification of most frequently associated bacteria #COVIDFOAM https://t.co/iDAyOwYekr pic.twitter.com/Z7N4V7tc7q — Intens Care Med […]
The post Bacterial and fungal superinfections in critically ill patients with COVID-19 appeared first on Links Medicus.
Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial – JAMA Internal Medicine Invited Commentary: Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)—Beware of Blind Spots Commentary on Twitter Preliminary findings from a randomized clinical trial suggest that […]
The post Preliminary randomized trial evaluated recombinant human granulocyte colony–stimulating factor for patients with COVID-19 and lymphopenia appeared first on Links Medicus.
COVID-19 and Pneumothorax: A Multicentre Retrospective Case Series – European Respiratory Journal Commentary: Another possible COVID complication: ‘Punctured lung’ – CIDRAP
The post COVID-19 and pneumothorax: A multicenter retrospective case series appeared first on Links Medicus.
NSAIDs like ibuprofen not tied to severe COVID-19, death – CIDRAP Original Study: Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study – PLOS Medicine Related: The case of ibuprofen: Evidence of huge impact of COVID-19 misinformation when coming from credible sources – Universitat […]
The post NSAIDs like ibuprofen not tied to severe COVID-19, death appeared first on Links Medicus.
Cochrane evidence on COVID-19: a round-up – Evidently Cochrane
The post Cochrane evidence on COVID-19: a round-up appeared first on Links Medicus.